HopeStage
Back to all studies
CompletedNCT00486083

Atomoxetine or methylphenidate for children with ADHD

About this titleRead the official source — NCT00486083

This study evaluated the safety and effectiveness of Atomoxetine Hydrochloride for people with ADHD.

Medication studyAges 6–16Multiple countries
The study in practice

Understand this study

What did researchers investigate?

This study evaluated the safety and effectiveness of Atomoxetine Hydrochloride for people with ADHD.

Who was this study for?

Listed age limits: 6 years to 16 years.

Listed locations
Shanghai and 2 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateDecember 2003
Recruitment status
Completed
Enrollment listed in the registry
330
Sponsor
Eli Lilly and Company
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
China, Mexico, South Korea
Age range
From 6 Years to 16 Years
Official registry ID
NCT00486083
Official title
Show the full official title

A Randomized, Double-Blind Comparison, Safety and Efficacy Trial of Atomoxetine Hydrochloride and Methylphenidate Hydrochloride in Pediatric Outpatients With DSM-IV Attention-Deficit/Hyperactivity Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Shanghai, China · Mexico City, Mexico · Seoul, South Korea

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

This study evaluated the safety and effectiveness of Atomoxetine Hydrochloride for people with ADHD.

Who is behind this study?

The study sponsor is Eli Lilly and Company.

Did this study involve medication?

Yes. The study involved medication, including Atomoxetine Hydrochloride and Methylphenidate Hydrochloride.

Who was this study for?

Listed age limits: 6 years to 16 years.

Want to explore more studies?

Explore studies